EP1675564A1 - Produits contenant de la valeriane - Google Patents

Produits contenant de la valeriane

Info

Publication number
EP1675564A1
EP1675564A1 EP04765860A EP04765860A EP1675564A1 EP 1675564 A1 EP1675564 A1 EP 1675564A1 EP 04765860 A EP04765860 A EP 04765860A EP 04765860 A EP04765860 A EP 04765860A EP 1675564 A1 EP1675564 A1 EP 1675564A1
Authority
EP
European Patent Office
Prior art keywords
acid
cognis
alcohol
valerian
fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP04765860A
Other languages
German (de)
English (en)
Inventor
Edith Bouchard
Dieter Goddinger
Jörg KAHRE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP1675564A1 publication Critical patent/EP1675564A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/382—Vegetable products, e.g. soya meal, wood flour, sawdust
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Definitions

  • the invention relates to compositions containing valerian and the use of these compositions for cleaning and maintaining surfaces such as glass, porcelain, wood, leather, fibers and in particular keratin fibers and skin.
  • Cosmetics for the care and maintenance of the natural functions of skin and hair are becoming increasingly important.
  • the changed consumer habits and fashion trends contribute to this.
  • the intensive use of tanning salons has a lasting impact on the structure of skin and hair by UV light.
  • These impairments are shown on the skin and hair, for example, by a loss of elasticity.
  • Emulsions for skin care are further optimized in terms of their irritant potential by selecting suitable emulsifiers.
  • Mild surfactants are used to clean the skin and hair so as not to put additional strain on the skin and hair.
  • Refatting substances are used to avoid stimulating sebum production during cleaning.
  • UV protection agents and vitamins such as vitamin E are said to reduce the adverse effects of UV light.
  • Protein hydrolyzates are used to balance the internal structure of the skin and hair. With plant and algae extracts, for example, the moisture balance of skin and hair can be influenced.
  • cosmetic active ingredients are increasingly used in agents for cleaning and maintaining surfaces such as glass, porcelain, leather, textiles, floors of all kinds in the household and in trade, in order not to put additional strain on the skin of the user of such products.
  • Hand dishwashing detergents with nourishing additives such as proteins or lipid-replenishing substances are available on the market.
  • valerian extracts as an active ingredient in agents for cleaning and maintaining surfaces shows surprisingly good properties.
  • valerian the undesirable effects such as burning or itching of the skin, feelings of tension etc. occur Users of these funds no longer.
  • valerian in these agents completely eliminates the need for preservatives or at least the amount of preservatives can be reduced.
  • a first object of the invention is therefore agents for the care and cleaning of surfaces containing conventional constituents, in particular surfactants and emulsifiers, characterized in that valerian extract is contained as the active ingredient.
  • Valerian is a plant that has been known and cultivated since ancient times. Valerian is used in numerous preparations in homeopathy and pharmacy. The numerous known effects of valerian include both sedating and activating effects. Valerian also shows cell toxic properties. Another very well-known property is the bitter taste. Valerian ingredients can be used as bitter substances and are used to stimulate the appetite. Furthermore, the taste of medicines and foods can be modified with valerian.
  • valerian As examples of the pharmaceutical use of valerian, reference is made to US 20030096865 AI. An extraction method for producing a valerian extract from the root of the valerian can be found, for example, in US 20030017110 AI. The use of valerian as a flavoring is described for example in EP 1077034 AI.
  • Valerian extracts are well-known herbal extracts. These extracts are usually produced by extracting the entire plant. In individual cases, however, it may also be preferred to produce the extracts exclusively from flowers and / or leaves and / or roots and / or stems or stems of the plant. In principle, all methods known to those skilled in the extraction field can be used for the production.
  • valerian can be extracted with solvents, in particular water, steam and alcohols, but also particularly gently with supercritical CO 2 or other supercritical fluids. Mixtures of water, steam and alcohols can also be used as extractants for the production of the valerian extract.
  • alcohols lower alcohols such as ethanol and isopropanol, but in particular polyhydric alcohols such as ethylene glycol and propylene glycol, are preferred, both as the sole extracting agent and in a mixture with water.
  • polyhydric alcohols such as ethylene glycol and propylene glycol
  • Valerian extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.
  • valerian ingredients can be used alone or in mixtures instead of the valerian extract.
  • these are preferably iridoids, in particular valtrate and valepotriate, sesquiterpenes such as in particular valeranone, terpene alkaloids such as, for example, actinidine, and valerian oil and tannins.
  • valeric acid is not preferred according to the invention. If valeric acid is used in accordance with the teaching of the present invention, then at least one further essential constituent of the valerian is also used.
  • valerian extract is also understood to be valerian oil obtained from the valerian plant in other ways.
  • the valerian extract can be used both in pure and in dilute form. If it is used in dilute form, it usually contains about 2 to 80% by weight of active substance and, as a solvent, the extractant or mixture of extractants used in its extraction.
  • valerian extract is used in the agents in amounts of 0.001 to 10% by weight, based on the total agent, preferably in amounts of 0.001 to 5% by weight and very particularly preferably in amounts of 0.005 to 3% by weight.
  • surfactants are understood to mean surface-active substances which form adsorption layers on surfaces and interfaces or which can aggregate in volume phases to form micelle colloids or lyotropic mesophases.
  • anionic surfactants consisting of a hydrophobic residue and a negatively charged hydrophilic head group
  • amphoteric surfactants which carry both a negative and a compensating positive charge
  • cationic surfactants which in addition to a hydrophobic residue have a positively charged hydrophilic group
  • nonionic surfactants which have no charges but strong dipole moments and are highly hydrated in aqueous solution.
  • Suitable anionic surfactants in preparations according to the invention are all anionic surface-active substances suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. B. a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group with about 8 to 30 carbon atoms.
  • anionic group such as. B. a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group with about 8 to 30 carbon atoms.
  • glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups can be contained in the molecule.
  • suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts with 2 to 4 carbon atoms in the alkanol group,
  • alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group with 8 to 30 C atoms and x 0 or 1 to 12, mixtures of surface-active hydroxysulfonates according to DE -A-3725 030, sulfated hydroxyalkyl polyethylene and / or hydroxyalkylene propylene glycol ethers according to DE-A-3723 354, sulfonates of unsaturated fatty acids with 8 to 24 C atoms and 1 to 6 double bonds according to DE-A-39 26 344,
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 carbon atoms,
  • Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride as well as their ethylene oxide adducts or their formulated with sulfuric acid trioxide.
  • Monoglyceride sulfates of the formula (VIII) are preferably used in which R CO represents a linear acyl radical having 8 to 18 carbon atoms.
  • Monoglyceride sulfates and monoglyceride ether sulfates are described, for example, in EP-Bl 0 561 825, EP-Bl 0 561 999, DE-Al 42 04 700 or by AKBiswas et al. in J.Am.Oil.Chem.Soc. 37, 171 (1960) and FUAhmed in J.Am.Oil.Chem.Soc. 67, 8 (1990).
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids with 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule and sulfosuccinic acid and dialkyl esters with 8 to 18 carbon atoms in the alkyl group and sulfosuccinic acid mono-alkyl polyoxyethyl ester with 8 up to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one -COO (_)
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example the cocoalkyl-dimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium- glycinates, for example the cocoacylaminopropyl dimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group, and also the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is that among the L CI name Cocamidopropyl Betaine known fatty acid amide derivative.
  • Ampholytic surfactants are surface-active compounds which, in addition to a C 8 -C 24 alkyl or acyl group, contain at least one free amino group and at least one -COOH or -SO 3 H group in the molecule and are capable of forming internal salts .
  • suitable ampholytic surfactants are N-alkylglycine, N-alkylpropionic acid, N-alkylaminobutyric acid, N- alkyliminodipropionic acid, N-hydroxyethyl-N-alkylamidopropylglycine, N-
  • Alkyltaurines N-alkyl sarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids, each with about 8 to 24 carbon atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylammopropionate and C 12 -C 18 acyl sarcosine.
  • Nonionic surfactants contain z as a hydrophilic group.
  • B a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group.
  • Such connections are, for example
  • Polyol fatty acid esters such as the commercial product Hydagen ® HSP (Cognis) or Sovermol - types (Cognis), alkoxylated triglycerides, alkoxylated fatty acid alkyl esters of the formula R 37 CO- (OCH 2 CHR 38) w OR 39, (IX) in which R 37 CO represents a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R 38 represents hydrogen or methyl, R 39 represents linear or branched alkyl radicals having 1 to 4 carbon atoms and w represents numbers from 1 to 20, amine oxides,
  • Alkyl polygycosides according to the general formula RO- (Z) x where R is alkyl, Z is sugar and x is the number of sugar units.
  • the alkyl polyglycosides which can be used according to the invention can contain only one specific alkyl radical R. Usually, however, these compounds are made from natural fats and oils or mineral oils. In this case, the alkyl radicals are R Mixtures corresponding to the starting compounds or corresponding to the respective processing of these compounds.
  • Any mono- or oligosaccharides can be used as the sugar building block Z.
  • Sugar with 5 or 6 carbon atoms and the corresponding oligosaccharides are usually used.
  • sugars are glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, old rose, mannose, gulose, idose, talose and sucrose.
  • Preferred sugar components are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred.
  • alkyl polyglycosides which can be used according to the invention contain on average 1.1 to 5 sugar units. Alkyl polyglycosides with x values from 1.1 to 2.0 are preferred. Alkyl glycosides in which x is 1.1 to 1.8 are very particularly preferred.
  • alkoxylated homologs of the alkyl polyglycosides mentioned can also be used in accordance with the invention. These homologues can contain an average of up to 10 ethylene oxide and / or propylene oxide units per alkyl glycoside unit.
  • the alkylene oxide adducts with saturated linear fatty alcohols and fatty acids, each with 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid, have proven to be preferred nonionic surfactants. Preparations with excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants. These connections are characterized by the following parameters.
  • the alkyl radical R contains 6 to 22 carbon atoms and can be either linear or branched. Primary linear and methyl-branched aliphatic radicals in the 2-position are preferred.
  • alkyl radicals examples include 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl.
  • 1-Octyl, 1-decyl, 1-lauryl, 1-myristyl are particularly preferred.
  • oxo alcohols compounds with an odd number of carbon atoms in the alkyl chain predominate.
  • the compounds with alkyl groups used as surfactant can each be uniform substances. However, it is generally preferred to start from natural vegetable or animal raw materials in the production of these substances, so that substance mixtures with different alkyl chain lengths depending on the respective raw material are obtained.
  • both products with a "normal” homolog distribution and those with a narrowed homolog distribution can be used.
  • “Normal” homolog distribution is understood to mean mixtures of homologs which are obtained as catalysts from the reaction of fatty alcohol and alkylene oxide using alkali metals, alkali metal hydroxides or alkali metal alcoholates.
  • narrow homolog distributions are obtained if, for example, hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or alcoholates are used as catalysts. The use of products with a narrow homolog distribution can be preferred.
  • surfactants are used in amounts of 0.1-45% by weight, preferably 1-30% by weight and very particularly preferably 1-15% by weight, based on the total agent.
  • nonionic, zwitterionic and / or amphoteric surfactants and mixtures thereof can be preferred.
  • Cationic surfactants of the type of the quaternary ammonium compounds, the esterquats and the amidoamines can also be used according to the invention.
  • Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammomum chlorides and trialkylmethylammonium chlorides, e.g. B.
  • cetyl trimethylammonium chloride Stearyltri- methyl ammonium chloride, distearyl dimethyl ammonium chloride, lauryl dimethyl ammonium chloride, Lauryldimethylbenzylammom 'monium chloride and Tricetylmethyl- ammonium chloride, as well as under the FNCI names Quaternium-27 and Quaternium-83 imidazolium compounds known.
  • the long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.
  • Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
  • Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are sold, for example, under the trademarks Stepantex ® , Dehyquart ® and Armocare ® .
  • the alkylamidoamines are usually produced by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines.
  • An inventively particularly suitable compound from this group is that available under the name Tegoamid ® S 18 commercially stearamidopropyl dimethylamine.
  • the cationic surfactants are preferably present in the agents used according to the invention in amounts of 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5% by weight are particularly preferred.
  • the compulsory surfactant and / or emulsifier components according to the invention also include the emulsifiers defined as follows: emulsifiers cause water or oil-stable adsorption layers to form at the phase interface, which protect the dispersed droplets against coalescence and thus stabilize the emulsion. Like surfactants, emulsifiers are therefore made up of a hydrophobic and a hydrophilic part of the molecule. Hydrophilic emulsifiers preferably form O / W emulsions and hydrophobic emulsifiers preferably form W / O emulsions.
  • An emulsion is to be understood as a droplet-like distribution (dispersion) of a liquid in another liquid with the use of energy to create stabilizing phase interfaces by means of surfactants.
  • the selection of these emulsifying surfactants or emulsifiers is based on the substances to be dispersed and the respective outer phase as well as the proportion of the emulsion. Further definitions and properties of emulsifiers can be found in "H.-D. Dörfler, interfacial and colloid chemistry, VCH Verlagsgesellschaft mbH. Weinheim, 1994 ".
  • Emulsifiers which can be used according to the invention are, for example: addition products of 4 to 30 mol of ethylene oxide and / or 0 to 5 mol of propylene oxide with linear fatty alcohols with 8 to 22 C atoms, with fatty acids with 12 to 22 C atoms and with alkylphenols 8 to 15 carbon atoms in the alkyl group, C 12 -C 22 fatty acid monoesters and diesters of adducts of 1 to 30 moles of ethylene oxide with polyols with 3 to 6 carbon atoms, in particular with glycerol, ethylene oxide and polyglycerol adducts with methylglucoside Fatty acid esters, fatty acid alkanolamides and fatty acid glucamides, C 8 -C 22 alkyl mono- and oligoglycosides and their ethoxylated analogs, degrees of oligomerization of 1.1 to 5, in particular 1.2 to 2.0, and glucose as the sugar component being preferred, mixtures of
  • Sterols are understood to be a group of steroids which carry a hydroxyl group on the C atom 3 of the steroid structure and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Sterols, the so-called mycosterols, are also isolated from mushrooms and yeasts. Phospholipids. These are understood above all to mean the glucose phospholipids which are obtained, for example, as lecithins or phosphatidylcholines from, for example, egg yolk or plant seeds (for example soybeans).
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol, polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ® PGPH), linear and branched fatty acids with 8 to 30 C atoms and their Na, K, ammonium, Ca, Mg and Zn salts.
  • the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
  • compositions according to the invention can preferably contain at least one nonionic emulsifier with an HLB value of 8 to 18, according to the 10th edition, Georg Thieme Verlag Stuttgart, New York, in the Römpp Lexicon Chemie (Ed. J. Falbe, M. Regitz). (1997), page 1764, contain the definitions listed.
  • Nonionic emulsifiers with an HLB value of 10-15 can be particularly preferred according to the invention.
  • the emulsifiers which contain no ethylene oxide and / or propylene oxide in the molecule can be very particularly preferred.
  • the effect can be increased further using polymers.
  • Polymers are understood to mean both natural and synthetic polymers which can be anionic, cationic, amphoteric or non-ionic.
  • Cationic polymers are understood to mean polymers which have groups in the main and / or side chain which can be “temporary” or “permanent” cationic.
  • "permanently cationic” means those polymers which have a cationic group irrespective of the pH of the agent. These are generally polymers which contain a quaternary nitrogen atom, for example in the form of an ammonium group.
  • Preferred cationic groups are quaternary ammonium groups Polymers in which the quaternary ammonium group is bonded via a C 1-4 hydrocarbon group to a polymer main chain composed of acrylic acid, methacrylic acid or their derivatives have proven to be particularly suitable.
  • R -H or -CH 3
  • R, R and R are independently selected from C 1- alkyl, alkenyl or hydroxyalkyl groups
  • m 1, 2, 3 or 4
  • n is a natural number
  • X is a physiologically acceptable organic or inorganic
  • Anion and copolymers consisting essentially of the monomer units listed in formula (DI) and nonionic monomer units are particularly preferred cationic polymers.
  • - R 1 R stands for a methyl group - R 19
  • R 20 and R 21 stand for methyl groups - m has the value 2.
  • Suitable physiologically acceptable counterions X " are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions.
  • halide ions in particular chloride, are preferred.
  • a particularly suitable homopolymer is the, if desired crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the L CI-
  • the crosslinking can be carried out with the aid of polyolefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylene bisacrylamide, diallyl ether, polyallylpolyglyceryl ether, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
  • Methylene bisacrylamide is a preferred crosslinking agent.
  • the homopolymer is preferably used in the form of a non-aqueous polymer dispersion which should not have a polymer content below 30% by weight.
  • a non-aqueous polymer dispersion which should not have a polymer content below 30% by weight.
  • Such polymer dispersions are available under the names Salcare ® SC 95 (approx. 50% polymer content, further components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene ether (INCI name: PPG-1-Trideceth- 6)) and Salcare ® SC 96 (approx.
  • a preferred copolymer according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer.
  • cationic polymers are, for example, - quaternized cellulose derivatives, such as are available under the names of Celquat ® and Polymer JR ® commercially.
  • the compounds Celquat ® H 100, Celquat ® L 200 and Polymer JR ® 400 are preferred quaternized cellulose derivatives, - cationic alkyl polyglycosides according to DE-PS 44 13 686, - canonized honey, for example the commercial product Honeyquat ® 50, - cationic guar derivatives, such as in particular the products sold under the trade names cos media ® guar and Jaguar ®, - polysiloxanes with quaternary groups, such as the commercially available products Q2-7224 (manufacturer: Dow Corning; a stabilized trimethyl silylamodimethicon), Dow Corning ® 929 emulsion (containing a hydroxylamino-modified silicone, which is also known as amodimethicone), SM-2059 (
  • Goldschmidt diquaternary polydimethylsiloxanes, quaternium-80), - polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic ure.
  • the products commercially available under the names Merquat ® 100 (poly (dimethyldiallylammonium chloride)) and Merquat ® 550 (dimethyldiallylammomum chloride-acrylamide copolymer) are examples of such cationic polymers, Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate, such as, for example, vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers quaternized with diethyl sulfate.
  • Such compounds are available under the names Gafquat ® 734 and Gafquat ® 755 commercially, vinylpyrrolidone-vinyl imidazolium copolymers, such as those offered under the names Luviquat ® FC 370, FC 550, FC 905 and HM 552, quaternized polyvinyl alcohol, as well as the under the names Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 known polymers with quaternary nitrogen atoms in the main polymer chain.
  • cationic polymers of the invention are the "temporarily cationic" polymers. These polymers usually contain an amino group present at certain pH values as a quaternary ammonium group and thus cationic are preferred, for example, chitosan and its derivatives, such as, for example, under the trade designations Hydagen ®. , Hydagen® ® HCMF, Kytamer ® PC and Chitolam ® NB / 101 are freely available commercially CMF. chitosans are deacetylated, in different degrees of deacetylation and varying degrees of degradation (molecular weights) are commercially available. Their preparation is, for example, in DE 44 40 625 AI and described in DE 1 95 03 465 AI. Chitosans which are particularly suitable have a degree of deacetylation of at least 80% and a molecular weight of 5 '10 5 to 5 "10 6 (g / mol).
  • the chitosan must be converted into the salt form. This can be done by dissolving in dilute aqueous acids.
  • Mineral acids such as e.g. Hydrochloric acid, sulfuric acid and phosphoric acid as well as organic acids, e.g. low molecular weight carboxylic acids, polycarboxylic acids and hydroxycarboxylic acids are suitable.
  • Higher molecular weight alkylsulfonic acids or alkylsulfuric acids or organophosphoric acids can also be used, provided that they have the required physiological tolerance.
  • Suitable acids for converting the chitosan into the salt form are e.g.
  • Low molecular weight hydroxycarboxylic acids such as e.g. Glycolic acid or lactic acid is used.
  • anionic polymers which can support the action of the active ingredient according to the invention are anionic polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers can consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups can be present in whole or in part as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer have proven to be very particularly effective, it being possible for the sulfonic acid group to be present in whole or in part as a sodium, potassium, ammonium, mono- or triethanolammonium salt ,
  • the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid for example, under the name Rheothik ®! 1-80 is commercially available.
  • copolymers of at least one anionic monomer and at least one nonionic monomer are acrylamide, methacrylamide, acrylic acid ester, methacrylic acid ester, vinyl pyrrolidone, vinyl ether and vinyl ester.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with monomers containing sulfonic acid groups.
  • a particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, the sulfonic acid group being wholly or partly as sodium, potassium, ammonium, mono- or triethanolammonium Salt is present.
  • This copolymer can also be crosslinked, the preferred crosslinking agents being polyolefinically unsaturated compounds such as tetraallyloxyethane, allyl sucrose, allylpentaerythritol and methylene bisacrylamide.
  • Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene can be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially. Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-preserving polymers. A maleic acid-methyl vinyl ether copolymer crosslinked with 1,9-decadiene is commercially available under the name Stabileze ® QM.
  • amphoteric polymers can be used as a component to increase the activity of the active ingredient according to the invention.
  • amphoteric polymers includes both those polymers which contain both free amino groups and free -COOH or SO 3 H groups in the molecule and are capable of forming internal salts, and also zwitterionic polymers which contain quaternary ammonium groups and -COO in the molecule Contain " - or -SO 3 " groups, and summarize those polymers which contain -COOH or SO 3 H groups and quaternary ammonium groups.
  • amphopolymer suitable is that available under the name Amphomer ® acrylic resin which is a copolymer of tert-butylaminoethyl methacrylate, N- (1,1,3,3-tetramethylbutyl) -acrylamide and two or more monomers from the group acrylic acid, methacrylic and represents their simple esters.
  • Amphomer ® acrylic resin which is a copolymer of tert-butylaminoethyl methacrylate, N- (1,1,3,3-tetramethylbutyl) -acrylamide and two or more monomers from the group acrylic acid, methacrylic and represents their simple esters.
  • Amphoteric polymers which are preferably used are those polymers which essentially consist of one another
  • R 22 -CH CR 23 -CO-Z- (C n H 2n ) -N (+) R 24 R 25 R 26 A w (TV) in which R 22 and R 23 independently of one another represent hydrogen or a methyl group and R 24 , R 25 and R 26 independently of one another represent alkyl groups with 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer from 2 to 5 and A ⁇ is the anion of an organic or inorganic acid and
  • R 27 -CH CR 28 -COOH (V) in which R 27 and R 28 are independently hydrogen or methyl groups.
  • these compounds can be used both directly and in salt form, which is obtained by neutralizing the polymers, for example with an alkali metal hydroxide.
  • an alkali metal hydroxide for example, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium carbonate, sodium sulfate, sodium bicarbonate, sodium sulfate, sodium sulfate, sodium bicarbonate, sodium sulfate, sodium bicarbonate, sodium sulfate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium sulfate, sodium bicarbonate, sodium bicarbonate, sodium sulfate
  • the agents according to the invention can also contain nonionic polymers.
  • Suitable nonionic polymers include: vinyl pyrrolidone / Vinylester copolymers, as are marketed, for example under the trademark Luviskol ® (BASF). Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers. Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and methylhydroxypropyl cellulose, as sold for example under the trademark Culminal® ® and Benecel ® (AQUALON).
  • Siloxanes are both water-soluble and water-insoluble. Both volatile and non-volatile siloxanes are suitable, non-volatile siloxanes being understood to mean those compounds whose boiling point is above 200 ° C. at normal pressure.
  • Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups.
  • polydialkylsiloxanes such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups.
  • the preparations used contain several, in particular two different polymers of the same charge and / or each contain an ionic and an amphoteric and / or non-ionic polymer.
  • the term polymer is also understood to mean special preparations of polymers such as spherical polymer powders.
  • Various methods are known for producing such microspheres from different monomers, for example by special polymerization processes or by dissolving the polymer in a solvent and spraying it into a medium in which the solvent can evaporate or diffuse out of the particles.
  • Suitable polymers are, for example, polycarbonates, polyurethanes, polyacrylates, polyolefins, polyesters or polyamides.
  • Spherical polymer powders whose primary particle diameter is less than 1 ⁇ m are particularly suitable.
  • Such products based on a polymethacrylate copolymer are, for example, under the Trademark Polytrap ® Q5-6603 (Dow Corning) commercially.
  • Other polymer powders e.g. based on polyamides (nylon 6, nylon 12) are available with a particle size of 2 - 10 ⁇ m (90%) and a specific surface area of approx. 10 m 2 / g under the trade name Orgasol ® 2002 DU Nat Cos ( Atochem SA, Paris) available.
  • spherical polymer powders which are suitable for the purpose according to the invention are, for example, the polymethacrylates (Micropearl M) from SEPPIC or (Plastic Powder A) from NIKKOL, the styrene-divinylbenzene copolymers (Plastic Powder FP) from NIKKOL, the polyethylene and polypropylene Powder (ACCUREL EP 400) from AKZO, or also silicone polymers (Silicone Powder X2-1605) from Dow Corning or spherical cellulose powder.
  • the polymethacrylates (Micropearl M) from SEPPIC or (Plastic Powder A) from NIKKOL
  • Plastic Powder FP styrene-divinylbenzene copolymers
  • ACCUREL EP 400 polyethylene and polypropylene Powder
  • silicone polymers Silicone Powder X2-1605
  • the polymers are preferably present in the agents used according to the invention in amounts of 0.01 to 10% by weight, based on the total agent. Amounts from 0.1 to 5, in particular from 0.1 to 3% by weight are particularly preferred.
  • the effect can be further increased by using protein hydrolyzates and their derivatives.
  • Protein hydrolyzates are product mixtures that are obtained by acidic, basic or enzymatically catalyzed breakdown of proteins (proteins).
  • protein hydrolyzates of both vegetable and animal origin can be used.
  • Animal protein hydrolyzates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolyzates, which can also be in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois ® (Interorgana), Collapuron ® (Cognis), Nutrilan ® (Cognis), Gelita-Sol ® (Deutsche Gelatine Fabriken Stoess & Co), Lexein ® (Inolex) and Kerasol ® (Croda) sold.
  • protein hydrolysates of plant origin e.g. B. soybean, almond, rice, pea, potato and Wheat protein.
  • Such products are available, for example, under the trademarks Gluadin ® (Cognis), DiaMin ® (Diamalt), Lexein ® (Inolex) and Crotein ® (Croda).
  • the silk proteins sericin and fibroin and their derivatives can be very particularly preferred.
  • amino acid mixtures or individual amino acids such as arginine, lysine, histidine or pyrroglutamic acid, which have otherwise been obtained, can optionally be used in their place.
  • derivatives of the protein hydrolyzates for example in the form of their fatty acid condensation products. Such products are sold for example under the names Lamepon ® (Cognis), Gluadin ® (Cognis), Lexein ® (Inolex), Crolastin ® (Croda) or Crotein ® (Croda).
  • Cationized protein hydrolyzates can also be used according to the invention, the underlying protein hydrolyzate being derived from animals, for example from collagen, milk or keratin, from plants, for example from wheat, corn, rice, potatoes, soy or almonds, from marine life forms, for example from fish collagen or algae , or from biotechnologically obtained protein hydrolyzates.
  • the protein hydrolysates on which the cationic derivatives according to the invention are based can be obtained from the corresponding proteins by chemical, in particular alkaline or acidic hydrolysis, by enzymatic hydrolysis and / or a combination of both types of hydrolysis.
  • the hydrolysis of proteins usually results in a protein hydrolyzate with a molecular weight distribution of approximately 100 daltons up to several thousand daltons.
  • Preferred cationic protein hydrolyzates are those whose underlying protein content has a molecular weight of 100 to 25,000 Daltons, preferably 250 to 5000 Daltons.
  • Cationic protein hydrolyzates also include quaternized amino acids and their mixtures. The quaternization of the protein hydrolyzates or the amino acids is frequently carried out using quaternary ammonium salts such as, for example, N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) -ammomumhalogeniden.
  • the cationic protein hydrolyzates can also be further derivatized.
  • inventive cationic protein hydrolysates and derivatives are under the INCI - th names in the "International Cosmetic Ingredient Dictionary and Handbook" (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 Street, NW, Suite 300, Washington , DC 20036-4702) and commercially available products: Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimopnium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice , Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Cocodimonium Hydroxypropyl Silk Amino Acids, Hydroxypropyl Arginine Lauryl / Myristy
  • the agents used according to the invention contain the protein hydrolyzates and their derivatives in amounts of 0.01-10% by weight, based on the total agent. Amounts of 0.1 to 5% by weight, in particular 0.1 to 3% by weight, are very particularly preferred.
  • the action of the active ingredient according to the invention can be further optimized by means of fatty substances.
  • Fat substances are to be understood as meaning fatty acids, fatty alcohols, natural and synthetic waxes, which can be present both in solid form and in liquid form in aqueous dispersion, and natural and synthetic cosmetic oil components.
  • Linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms can be used as fatty acids.
  • Fatty acids with 10-22 carbon atoms are preferred.
  • isostearic as the commercial products Emersol ® 871 and Emersol ® 875
  • isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • fatty acids are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, galeoacheneic acid, elenachearic acid and erucic acid and their technical mixtures, which are obtained, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxosynthesis or in the dimerization of unsaturated fatty acids.
  • the fatty acid cuts which are obtainable from coconut oil or palm oil are usually particularly preferred; the use of stearic acid is generally particularly preferred.
  • the amount used is 0.1-15% by weight, based on the total agent. In a preferred embodiment, the amount is 0.5-10% by weight, with amounts of 1-5% by weight being very particularly advantageous.
  • Saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 -C 30 , preferably C 10 -C 22 and very particularly preferably C 12 -C 22 carbon atoms can be used as fatty alcohols.
  • the fatty alcohols derive from preferably natural fatty acids, and it can usually be assumed that they are obtained from the esters of the fatty acids by reduction.
  • suitable according to the invention are those fatty alcohol cuts which are produced by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® , for example Stenol ® 1618 or Lanette ® , for example Lanette ® O or Lorol ® , for example Lorol ® C8, Lorol ® C14, Lorol ® C18, Lorol ® C8-18, HD-Ocenol ® , Crodacol ® , e.g.
  • wool wax alcohols such as those commercially available under the names Corona ® , White Swan ® , Coronet ® or Fluilan ® , can also be used.
  • the fatty alcohols are used in amounts of 0.1-20% by weight, based on the entire preparation, preferably in amounts of 0.1-10% by weight.
  • Solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, walnut, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes made of PE or PP can be used according to the invention as natural or synthetic waxes.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the natural and synthetic cosmetic oil bodies which can increase the effect of the active ingredient according to the invention include, for example: vegetable oils.
  • vegetable oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach seed oil and the liquid components of coconut oil.
  • Other triglyceride oils such as the liquid portions of beef tallow and synthetic triglyceride oils are also suitable.
  • Ester oils are understood to be the esters of C 6 -C 30 fatty acids with C 2 -C 30 fatty alcohols. The monoesters of fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • fatty acid constituents used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linoleic acid, arenachic acid, araoleic acid, araoleic acid, araoleic acid, araelostic acid, elaostelic acid, elaoleic acid, elaostic acid, elaostic acid Erucic acid and its technical mixtures, which occur, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxosynthesis or in the dimerization of unsaturated fatty acids.
  • Fatty alcohol fractions in the ester oils are isopropyl alcohol, capron alcohol, caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, elaidyl alcohol - nyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures, which are obtained, for example, in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from Roelen's oxosynthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols.
  • isopropyl myristate IPM Rilanit ®
  • isononanoic acid C16-18 alkyl ester Cetiol ® SN
  • 2-ethylhexyl palmitate Cegesoft ® 24
  • stearic acid-2-ethylhexyl ester Cetiol ® 868
  • cetyl oleate glycerol tricaprylate, Kokosfettalkohol- caprinate / caprylate (Cetiol ® LC), n-butyl stearate, olerlerucate (Cetiol ® J 600), isopropyl palmitate (Rilanit ® IPP), oleyl oleates (Cetiol ® ), hexyl laurate (Cetiol ® A), di-n-butyl adipate (Cetiol ® B), myr
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecylacelate as well as diol esters such as ethylene glycol dioleate, ethylene glycol di-isotridecanoate, propylene glycol di (2 -ethylhexanoate), propylene glycol di-isostearate, propylene glycol di-pelargonate, butanediol di-isostearate, neopentyl glycol dicaprylate, symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, for example described in DE-OS 197 56 454, glyceryl carbonate or dicaprylic carbonate Cetiol ® CC),
  • Mono, - di- and tri-fatty acid esters of saturated and / or unsaturated linear and / or branched fatty acids with glycerin such as Monomuls ® 90-018, Monomuls ® 90-L12 or Cutina ® MD.
  • the amount used is 0.1-50% by weight, based on the total agent, preferably 0.1
  • the total amount of oil and fat components in the agents according to the invention is usually 6-45% by weight, based on the total agent. Amounts of 10-35% by weight are preferred according to the invention.
  • hydroxycarboxylic acid esters are full esters of glycolic acid, lactic acid, malic acid, tartaric acid or citric acid.
  • Other generally suitable hydroxycarboxylic acid esters are esters of ⁇ -hydroxypropionic acid, tartronic acid, D-gluconic acid, sugar acid, mucic acid or glucuronic acid.
  • Suitable alcohol components of these esters are primary, linear or branched aliphatic alcohols with 8-22 C atoms, for example fatty alcohols or synthetic fatty alcohols.
  • the esters of C 12 -C 15 fatty alcohols are particularly preferred.
  • Esters of this type are commercially available, eg under the trademark Cosmacol® ® EniChem, Augusta Industriale.
  • the amount of the hydroxycarboxylic acid esters used is 0.1-15% by weight, based on the composition, preferably 0.1-10% by weight and very particularly preferably 0.1-5% by weight.
  • Vitamins, pro-vitamins and vitamin precursors which are usually assigned to groups A, B, C, E, F and H are preferred according to the invention.
  • the group of substances called vitamin A includes retinol (vitamin Ai) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as palmitate and acetate come into consideration as vitamin A components.
  • the preparations used according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the entire preparation.
  • the vitamin B group or the vitamin B complex include
  • Vitamin B 2 (riboflavin)
  • Vitamin B 3 The compounds nicotinic acid and nicotinamide (niacinamide) are often listed under this name. According to the invention, preference is given to nicotinic acid amide, which is preferably present in the agents used according to the invention in amounts of 0.05 to 1% by weight, based on the total agent.
  • Vitamin B 5 pantothenic acid and panthenol
  • panthenol is preferably used.
  • Derivatives of panthenol which can be used according to the invention are in particular the esters and ethers of panthenol, cationically derivatized panthenols and pantolactone.
  • Individual representatives are, for example, panthenol triacetate, panthenol monoethyl ether and its monoacetate and the cationic panthenol derivatives disclosed in WO 92/13829.
  • the compounds of the vitamin B 5 type mentioned are preferably present in the agents used according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5% by weight are particularly preferred.
  • Vitamin B 6 pyridoxine as well as pyridoxamine and pyridoxal.
  • Vitamin C (ascorbic acid). Vitamin C is preferably used in the agents used according to the invention in amounts of 0.1 to 3% by weight, based on the total agent. Use in the form of the palmitic acid ester, the glucosides or phosphates can be preferred. Use in combination with tocopherols may also be preferred.
  • Vitamin E tocopherols, especially ⁇ -tocopherol.
  • Tocopherol and its derivatives which include in particular the esters such as acetate, nicotinate, phosphate and succinate, are preferably present in the agents used according to the invention in amounts of 0.05-1% by weight, based on the total agent ,
  • Vitamin F usually means essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H The compound (3aS, 4S, 6ai?) - 2-oxohexa- hydrothienol [3,4-rf] -imidazole-4-valeric acid is designated as vitamin H, but for which the trivial name biotin has now become established.
  • Biotin is contained in the agents used according to the invention preferably in amounts of 0.0001 to 1.0% by weight, in particular in amounts of 0.001 to 0.01% by weight.
  • the agents used according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, E and H.
  • Panthenol and its derivatives as well as nicotinamide and biotin are particularly preferred.
  • extracts are usually produced by extracting the entire plant. In individual cases, however, it may also be preferred to produce the extracts exclusively from flowers and / or leaves of the plant.
  • the extracts from green tea, almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi and melon are particularly suitable for the use according to the invention.
  • Alcohols and mixtures thereof can be used as extractants for the production of the plant extracts mentioned.
  • alcohols lower alcohols such as ethanol and isopropanol, but in particular polyhydric alcohols such as ethylene glycol and propylene glycol, are preferred, both as the sole extracting agent and as a mixture with water.
  • Plant extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.
  • the plant extracts can be used both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80% by weight of active substance and, as a solvent, the extractant or extractant mixture used in their extraction.
  • mixtures of several, in particular two, different plant extracts in the agents according to the invention may be preferred.
  • the action of the active ingredient according to the invention can be further increased in the compositions according to the invention in combination with substances which contain primary or secondary amino groups.
  • amino compounds are ammonia, monoethanolamine, 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-propanediol and basic amino acids such as lysine, arginine or histidine.
  • these amines can also be in the form of the corresponding salts with inorganic and / or organic acids are used, such as ammonium carbonate, ammonium citrate, ammonium oxalate, ammonium tartrate or lysine hydrochloride.
  • the amines are used together with the active ingredient according to the invention in ratios of 1:10 to 10: 1, preferably 3: 1 to 1: 3 and very particularly preferably in stoichiometric amounts.
  • these preparations can in principle contain all further components known to those skilled in the art for such cosmetic compositions.
  • - Thickeners such as gelatin or vegetable gums, for example agar agar, guar gum, alginates, xanthan gum, gum arabic, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. As methyl cellulose, hydroxyalkyl cellulose and carboxymethyl cellulose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays and layered silicates such as.
  • B. bentonite or fully synthetic hydrocolloids such.
  • Solvents and intermediates such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerin and diethylene glycol,
  • active ingredients that improve fiber structure in particular mono-, di- and oligosaccharides such as, for example, glucose, galactose, fructose, fructose and lactose,
  • quaternized amines such as methyl 1-alkylamidoethyl-2-alkylimidazolime * um methosulfate,
  • anti-dandruff agents such as piroctone olamine, zinc omadine and climbazol, Light stabilizers, in particular derivatized benzophenones, cinnamic acid derivatives and triazines,
  • Swelling and penetration substances such as glycerol, propylene glycol monoethyl ether, carbonates, hydrogen carbonates, guanidines, ureas and primary, secondary and tertiary phosphates,
  • Ceramides are understood to mean N-acylsphingosine (fatty acid amides of sphingosine) or synthetic analogs of such lipids (so-called pseudo-ceramides),
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescent agents such as ethylene glycol mono- and distearate and PEG-3 distearate,
  • Propellants such as propane-butane mixtures, N 2 O, dimethyl ether, CO 2 and air,
  • these preparations are, for example, creams, lotions, solutions, water, emulsions such as W / O, O / W, PIT emulsions (emulsions according to the Teaching of phase inversion, called PIT), microemulsions and multiple emulsions, coarse, unstable, single or multi-phase shake mixtures, gels, sprays, aerosols and foam aerosols.
  • emulsions such as W / O, O / W
  • PIT emulsions emulsions according to the Teaching of phase inversion, called PIT
  • microemulsions and multiple emulsions coarse, unstable, single or multi-phase shake mixtures
  • gels, sprays, aerosols and foam aerosols are usually formulated on an aqueous or aqueous alcohol basis.
  • Lower alkanols and polyols such as propylene glycol and glycerol are used as the alcoholic component. Ethanol and isopropanol are preferred alcohols
  • Water and alcohol can be present in the aqueous alcoholic base in a weight ratio of 1:10 to 10: 1.
  • Water and aqueous-alcoholic mixtures which contain up to 50% by weight, in particular up to 25% by weight, of alcohol, based on the alcohol / water mixture, can be preferred bases according to the invention.
  • the pH of these preparations can in principle be between 2 and 11. It is preferably between 2 and 7, values from 3 to 5 being particularly preferred. Virtually any acid or base that can be used for cosmetic purposes can be used to adjust this pH.
  • Food acids are usually used as acids.
  • Edible acids are those acids that are taken in as part of the usual food intake and have positive effects on the human organism.
  • Edible acids are, for example, acetic acid, lactic acid, tartaric acid, citric acid, malic acid, ascorbic acid and gluconic acid.
  • citric acid and lactic acid is particularly preferred.
  • Preferred bases are ammonia, alkali metal hydroxides, monoethanolamine, triethanolamine and N, N, N ', N'-tetrakis (2-hydroxypropyl) ethylenediamine.
  • Preparations remaining on the skin and hair have proven to be particularly effective and can therefore represent preferred embodiments of the teaching according to the invention. Remaining on the skin and hair according to the invention are understood to mean those preparations which are not rinsed off or rinsed out of the skin or from the hair again in the course of the treatment after a period of a few seconds to an hour with the aid of water or an aqueous solution , Rather, the preparations remain on the skin or hair until the next wash. According to a preferred embodiment for use on the hair, these preparations are formulated as a hair treatment or hair conditioner.
  • the preparations according to the invention in accordance with this embodiment can be rinsed out with water or an at least predominantly water-containing agent after this exposure time has expired; however, as stated above, they are preferably left on the hair. It may be preferred to apply the preparation according to the invention to the hair before using a cleaning agent, a waving agent or other hair treatment agents. In this case, the preparation according to the invention serves as color protection for the subsequent applications.
  • the agents according to the invention can also be, for example, cleansing agents for skin and hair, such as shampoos, makeup removers, facial cleansers, nourishing agents for skin and hair, such as douches, day creams, night creams, face masks, or firming agents for the skin
  • cleansing agents for skin and hair such as shampoos, makeup removers, facial cleansers
  • nourishing agents for skin and hair such as douches, day creams, night creams, face masks, or firming agents for the skin
  • hair such as hair setting agents, foam setting agents, styling gels and hair dryer shafts
  • permanent shaping agents such as permanent wave and fixing agents, and in particular pretreatment agents or rinses used in the course of a permanent wave process or dyeing process.
  • microemulsions are also understood to be so-called “PIT” emulsions.
  • PIT phase inversion temperature
  • these emulsions are systems with the 3 components water, oil and emulsifier, which are present as an oil-in-water (O / W) emulsion at room temperature.
  • O / W oil-in-water
  • PIT phase inversion temperature
  • O / W emulsions are formed, which, however, also at room temperature as microemulsions with an average particle diameter of less than 400 nm, in particular with a particle diameter of about 100-300 nm, available. Details regarding these very stable, low-viscosity systems, for which the term “PIT emulsions” has become generally accepted, can be found in a large number of publications, for which the publications in Angew. Chem. 97, 655-669 (1985) and Adv. Colloid Interface Sei 58, 119-149 (1995).
  • those micro- or “PIT” emulsions can be preferred which have an average particle diameter of approximately 200 nm.
  • the microemulsions according to the invention can be prepared, for example, by first determining the phase inversion temperature of the system by heating a sample of the emulsion prepared in the customary manner and using a conductivity meter to determine the temperature at which the conductivity decreases sharply.
  • the decrease in the specific conductivity of the O / W emulsion initially present generally decreases over a temperature range of 2 to 8 ° C from originally more than 1 mS / cm to values below 0.1 mS / cm. This temperature range then corresponds to the phase inversion temperature range.
  • the emulsion initially produced as usual, from the oil component, nonionic emulsifier, at least parts of the water and, if appropriate, further components can be heated to a temperature which is within or above the phase inversion temperature range, then cooled and optionally add other components as well as the remaining water.
  • the microemulsion can also be produced directly at a temperature which is within or above the phase inversion temperature range. The microemulsion thus produced is then cooled to a temperature below the phase inversion temperature range, usually room temperature.
  • the active ingredient is used in agents for dyeing keratin fibers.
  • the active ingredient according to the invention can be added directly to the colorant.
  • the application is preferably carried out of the active ingredient on the dyed keratin fiber, but in a separate step either directly after the actual dyeing process or in separate treatments, if appropriate also days or weeks after the dyeing process.
  • the term dyeing process includes all processes known to the person skilled in the art, in which a dye is applied to the optionally moistened hair and either left on the hair for a period of between a few minutes and about 45 minutes and then with water or a surfactant-containing agent is rinsed out or left entirely on the hair.
  • a dye is applied to the optionally moistened hair and either left on the hair for a period of between a few minutes and about 45 minutes and then with water or a surfactant-containing agent is rinsed out or left entirely on the hair.
  • monographs e.g. B. Kh. Schrader, Fundamentals and Recipes of Cosmetics, 2nd edition, Hüthig Buch Verlag, Heidelberg, 1989, referring to the corresponding knowledge of the expert.
  • composition of the dye or tint is not subject to any principle
  • Oxidation dye precursors of the developer and coupler type
  • Primary aromatic amines with a further free or substituted hydroxy or amino group in the para or ortho position, diaminopyridine derivatives, heterocyclic hydrazones, 4-aminopyrazole derivatives and 2,4,5,6-tetraaminopyrimidine are usually used as oxidation dye precursors of the developer type and its derivatives used.
  • Suitable developer components are, for example, p-phenylenediamine, p-toluenediamine, p-aminophenol, o-aminophenol, 1- (2'-hydroxyethyl) - 2,5-diaminobenzene, N, N-bis- (2-hydroxyethyl) -p-phenylenediamine, 2- (2,5-diaminophenoxy) ethanol, 4-amino-3-methylphenol, 2,4, 5,6-tetraaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2,4-dihydroxy-5,6-diaminopyrimidine, 2-dimethylamino-4,5, 6-triaminopyrimidine, 2-hydroxymethylamino-4-aminophenol, bis- (4-aminophenyl) amine, 4-amino-3-fluorophenol, 2-aminomethyl-4-aminophenol, 2-hydroxy
  • B. 4,5-diamino-l- (2'-hydroxyethyl) pyrazole Particularly advantageous developer components are p-phenylenediamine, p-toluenediamine, p-aminophenol, 1- (2'-hydroxyethyl) -2,5-diaminobenzene, 4-amino-3-methylphenol, 2-aminomethyl-4-aminophenol, 2,4 , 5, 6-tetraaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine.
  • M-Phenylenediamine derivatives, naphthols, resorcinol and resorcinol derivatives, pyrazolones and m-aminophenol derivatives are generally used as oxidation dye precursors of the coupler type.
  • coupler components are m-aminophenol and its derivatives such as 5-amino-2-methylphenol, 5- (3-hydroxypropylamino) -2-methylphenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy -4-aminophenoxyethanol, 2,6-dimethyl-3-aminophenol, 3-trifluoroacetylamino-2-chloro-6-methylphenol, 5-amino-4-chloro-2-methylphenol, 5-amino-4-methoxy-2-methylphenol , 5- (2'-Hydroxyethyl) amino-2-methylphenol, 3- (diethylamino) phenol, N-cyclopentyl-3-aminophenol, 1,3-dihydroxy-5- (methylamino) benzene, 3- (ethylamino ) -4-methylphenol and 2,4-dichloro-3-aminophenol, o-aminophenol and its derivatives, m-diaminobenzene and its derivatives,
  • Naphthalene derivatives such as 1-naphthol, 2-methyl-1-naphthol, 2-hydroxymethyl-1-naphthol, 2-hydroxyethyl-1-naphthol, 1,5-dihydroxynaphthalene, 1,6-dihydroxy naphthalene, 1, 7-dihydroxynaphthalene, 1,8-dihydroxynaphthalene, 2,7-dihydroxynaphthalene and 2,3-dihydroxynaphthalene, morpholine derivatives such as 6-hydroxybenzomorpholine and 6-amino-benzomorpholine, quinoxaline derivatives such as 6-methyl-1, 2, 3, 4-tetrahydroquinoxaline, pyrazole derivatives such as l-phenyl-3-methylpyrazol-5-one,
  • coupler components are 1-naphthol, 1,5-, 2,7- and 1,7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, resorcinol, 4-chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol and 2,6-dihydroxy-3,4-dimethylpyridine.
  • Direct dyes are usually nitrophenylenediamines, nitroammophenols, azo dyes, anthraquinones or indophenols.
  • Particularly suitable direct dyes are those under the international names or trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, Basic Yellow 57, Disperse Orange 3, HC Red 3, HC Red BN, Basic Red 76, HC Blue 2, HC Blue 12, Disperse Blue 3, Basic Blue 99 , HC Violet 1, Disperse Violet 1, Disperse Violet 4, Disperse Black 9, Basic Brown 16 and Basic Brown 17 known compounds as well as 1,4-bis (ß-hydroxyethyl) - amino-2-nitrobenzene, 4-amino-2 -nitrodiphenylamine-2'-carboxylic acid, 6-nitro-1,2,3,4-tetrahydroquinoxaline, hydroxyethyl-2-nitro-toluidine, picramic acid, 2-amino-6-chloro-4-nitrophenol, 4-ethylamino-3-
  • Directly occurring dyes found in nature include, for example, henna red, henna neutral, henna black, chamomile flowers, sandalwood, black tea, rotten tree bark, sage, blue wood, madder root, catechu, sedre and alkanna root.
  • oxidation dye precursors or the substantive dyes each represent uniform compounds. Rather, in the hair colorants according to the invention, due to the manufacturing process for the individual dyes, further components may be present in minor amounts, provided that these do not adversely affect the coloring result or for other reasons, e.g. B. toxicological, must be excluded.
  • indoles and indolines and their physiologically tolerable salts are used as precursors of nature-analogous dyes.
  • Those indoles and indolines are preferably used which have at least one hydroxyl or amino group, preferably as a substituent on the six-membered ring.
  • These groups can carry further substituents, e.g. B. in the form of etherification or esterification of the hydroxy group or an alkylation of the amino group.
  • N-methyl-5,6-dihydroxyindoline N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline and especially that 5,6-dihydroxyindoline and N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole and in particular the 5 6-dihydroxyindole.
  • the h dolin and hidol derivatives in the colorants used in the process according to the invention both as free bases and in the form of their physiologically tolerable salts with inorganic or organic acids, for.
  • amino acids are amino carboxylic acids, especially ⁇ -amino carboxylic acids and ⁇ -amino carboxylic acids.
  • Arginine, lysine, ornithine and histidine are again particularly preferred among the ⁇ -aminocarboxylic acids.
  • a very particularly preferred amino acid is arginine, especially in free form, but also used as the hydrochloride.
  • Hair colorants in particular if the coloring is oxidative, be it with atmospheric oxygen or other oxidizing agents such as hydrogen peroxide, are usually set to slightly acidic to alkaline, ie to pH values in the range from about 5 to 11.
  • the colorants contain alkalizing agents, usually alkali or alkaline earth metal hydroxides, ammonia or organic amines.
  • Preferred alkalizing agents are monoethanolamine, monoisopropanolamine, 2-amino-2-methyl-propanol, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-ethyl-1,3-propanediol, 2-amino-2 -methylbutanol and triethanolamine as well as alkali and alkaline earth metal hydroxides.
  • Monoethanolamine, triethanolamine and 2-amino-2-methyl-propanol and 2-amino-2-methyl-1,3-propanediol are particularly preferred in this group.
  • the use of ⁇ -amino acids such as ⁇ -aminocaproic acid as an alkalizing agent is also possible.
  • customary oxidizing agents such as in particular hydrogen peroxide or its adducts with urea, melamine or sodium borate, can be used.
  • oxidation with atmospheric oxygen as the only oxidizing agent can be preferred. It is also possible to carry out the oxidation with the aid of enzymes, the enzymes being used both for producing oxidizing per compounds and for enhancing the action of a small amount of oxidizing agents present, or also enzymes which release electrons from suitable developer components (reducing agents) Transmit atmospheric oxygen.
  • Oxidases such as tyrosinase, ascorbate oxidase and laccase are preferred, but also glucose oxidase, uricase or pyruvate oxidase. Furthermore, the procedure should be mentioned to increase the effect of small amounts (e.g. 1% and less, based on the total agent) of hydrogen peroxide by peroxidases.
  • the preparation of the oxidizing agent is then expediently mixed with the preparation with the dye precursors immediately before dyeing the hair.
  • the resulting ready-to-use hair dye preparation should preferably have a pH in the Range from 6 to 10. It is particularly preferred to use the hair dye in a weakly alkaline environment.
  • the application temperatures can be in a range between 15 and 40 ° C., preferably at the temperature of the scalp. After an exposure time of about 5 to 45, in particular 15 to 30, minutes, the hair dye is rinsed off the hair to be dyed. Washing with a shampoo is not necessary if a carrier with a high surfactant content, e.g. B. a coloring shampoo was used.
  • the preparation with the dye precursors can be applied to the hair without prior mixing with the oxidation component. After an exposure time of 20 to 30 minutes, the oxidation component is then applied, if necessary after an intermediate rinse. After a further exposure time of 10 to 20 minutes, rinsing is then carried out and, if desired, re-shampooing.
  • the corresponding agent is adjusted to a pH of about 4 to 7.
  • air oxidation is initially aimed for, the agent applied preferably having a pH of 7 to 10. In the subsequent accelerated postoxidation, the use of acidified peroxidisulfate solutions as the oxidizing agent can be preferred.
  • the formation of the color can be supported and increased by adding certain metal ions to the agent.
  • metal ions are, for example, Zn 2+ , Cu 2+ , Fe 2+ , Fe 3+ , Mn 2+ , Mn 4+ , Li + , Mg 2+ , Ca 2+ and Al 3+ .
  • Zn 2+ , Cu 2+ and Mn 2+ are particularly suitable.
  • the metal ions can be used in the form of any physiologically acceptable salt.
  • Preferred salts are the acetates, sulfates, halides, lactates and tartrates.
  • the active ingredient combination according to the invention can also be used in products for cleaning surfaces such as glass, porcelain, plastic, textiles, leather, lacquer or wood.
  • the active ingredient is particularly suitable, for example, for use in manual and machine dishwashing detergents, glass cleaners, bathroom and toilet cleaners, and floor cleaners and care products.
  • Another object of the invention is the use of the compositions according to the invention for cleaning and maintaining surfaces.
  • Another object of the invention is the use of the compositions according to the invention for cleaning and care of the skin or keratin fibers.
  • EMULGADE ® SE mixture of glyceryl stearate (and) 4.0
  • CETIOL ® LC (Cognis) Capryl / Coco-Caprylate / Caprate 5.0 Capric acid esters of saturated fatty alcohols C 12 - C 18
  • Viscosity (mPas), Brook.RVF, 23 ° C, Sp.TE, 4 rpm, 150000 with Helipath Rich night care ingredient Chemical name INCI name% by weight
  • LANETTE ® O cetylstearyl alcohol Cetearyl Alcohol 4.0
  • CETIOL ® J 600 liquid wax ester oleyl erucate 4.0
  • CETIOL ® V oleic acid decyl ester decyl oleate 4.0
  • CETIOL ® OE Di-n-Octyl Ether Dicaprylyl Ether 4.0 MYRITOL ® 318 (Cognis) Capryl / Caprylic / Capric 3.5 Capric Acid Triglyceride Triglyceride Baysilon ® M 350 (Bayer) Dimethicone 0.5 COPHEROL ® F 1300 RRR- ( ⁇ ) -Toco ⁇ herol Tocopherol 1.0 (Cognis) water ad 100 glycerin 86% 3.0 Carbopol ® 981 2% carbomer 10.0 KOH 20% 0.3 LIPOCUTLN ® (Cognis) Aqua (and) lecithin 5.0 (and) Cholesterol (and) Decetyl Phosphate
  • Viscosity mPas
  • Brookfield RVF 23 ° C
  • Sp.TE 4 rpm
  • CETIOL ® OE (Cognis) Di-n-octyl ether Dicaprylyl Ether 5.0
  • Zinc stearate (Bärlocher) Zinc stearate 1.0
  • Viscosity (mPas), Brookfield RVF, 23 ° C, spindle TE, 4 rpm, with Helipath approx. 200000
  • Zincum ® N 29 (from zinc stearate Zinc Stearate 1.0
  • CETIOL ® OE (Cognis) Di-n-octyl ether Dicaprylyl Ether 3.0
  • CETIOL ® LC (Cognis) Capryl / Capric Acid Coco 6.0 from saturated Caprylate / Caprate fatty alcohols C 12 - C 18
  • Myritol ® 312 (Cognis) caprylic / Caprylic / Capric Triglyceride 8.0 capric triglyceride
  • Viscosity mPas
  • Brookfield RVF
  • spindle TE Spindle TE
  • Helipath 150000 Naturally toning day cream
  • EMULGADE ® SE mixture of partial glycerides, glyceryl stearate (and) 6.0
  • CETIOL ® OE (Cognis) Di-n-octyl ether Dicaprylyl Ether 5.0
  • Viscosity mPas
  • Brookfield RVF, 23 ° C, spindle TE, 4
  • Leave-on hair treatment ingredient Chemical name INCI - Name wt.% DEHYQUART ® F 75 mixture of esterquat distearoylethyl 0.7 (Cognis) and fatty alcohol hydroxyethylmomum methosulfate (and) cetearyl alcohol DEHYMULS ® PGPH polyglycerol poly-12-polyglyceryl-2 1 , 0 (Cognis) hydroxystearate dipolyhydroxystearate LANETTE ® O (Cognis) cetylstearyl alcohol Cetearyl Alcohol 3.0 EUTANOL ® G (Cognis) 2-octyldodecanol octyldodecanol 0.2 (Guerbet alcohol) CETIOL ® J 600 (Cognis) liquid wax ester Oleyl Erucate 0 1 PLANTACARE ® 1200 C 12 - C 16 Lauryl Glucoside 2.5 UP (Cognis) fatty alcohol glycoside (approx.
  • valerian oil 1.0 water ad 100 GLUADIN ® W 40 partial hydrolyzate from hydrolyzed wheat 2.0 (Cognis) wheat (approx. 40%) protein panthenol (50%) 0.7 pH value 4 viscosity (mPas) / Brookfield, RVF 23 ° C, spindle 5, 10 rpm 6800 4.
  • Leave-on hair treatment 1.0 water ad 100 GLUADIN ® W 40 partial hydrolyzate from hydrolyzed wheat 2.0 (Cognis) wheat (approx. 40%) protein panthenol (50%) 0.7 pH value 4 viscosity (mPas) / Brookfield, RVF 23 ° C, spindle 5, 10 rpm 6800 4.
  • CETIOL ® J 600 (Cognis) liquid wax ester oleyl erucate 0.5
  • Hair mask constituent Chemical name INCI name% by weight DEHYQUART ® F 75 hybrid of esterquat distearoylethyl 3.0 (Cognis) and fatty alcohol hydroxyethylmonium methosulfate (and) cetearyl alcohol LANETTE ® O (Cognis) cetylstearyl alcohol Cetearyl Alcohol 4.0 CUTINA ® GMS (Cognis) glycerol monostearate glyceryl stearate 1.0 EUMULG ⁇ N ® B 2 polyoxyethylene-20-ceteareth-20 1.5 (Cognis) cetylstearyl alcohol valerian oil 1.0 NUTRILAN ® KERATIN partial hydrolyzate from hydrolyzed keratin 5.0 W (Cognis) keratin (approx. 20%) panthenol 0.8 aloe vera gel 2.0 water ad 100
  • 2-in-l shampoo constituent Chem name INCI - name wt.% TEXAPON ® N 70 sodium lauryl ether sulfate Sodium Laureth Sulfate 12.0 (Cognis) with 2 mol EO (approx. 70%) DEHYTON ® PK 45 fatty acid amide Derivative with cocamidopropyl 2.5 (Cognis) betaine structure (approx. 45%) PLANTACARE ® 818 UP C 8 - C 16 fatty alcohol Coco Glucoside 3.0 (Cognis) glycoside (approx.
  • Viscosity (mPas), Brookfield RFT, 23 ° C, column 4, 10 rpm 6300
  • Conditioning shampoo constituent Chemical name INCI name Weight% TEXAPON ® N 70 sodium lauryl ether sulfate Sodium Laureth Sulfate 10.0 (Cognis) with 2 mol EO (approx. 70%) PLANTACARE ® 818 UP C 8 - C 16 fatty alcohol coco glucoside 4.0 (Cognis) glycoside (approx. 50%) DEHYTON ® K (Cognis) fatty acid amide derivative Cocamidopropyl Betaine 5.0 with betaine structure (approx.
  • Baby shampoo, without preservative Component Chemical name INCI name Weight% water ad 100 polymer ® JR 400 polyquaternium 10 0.4 (Amerchol) TEXAPON ® K 14 S sodium lauryl myristyl ether sodium myreth 11.0 special 70% (Cognis) sulfate ( 70%) sulfates DEHYTON ® PK 45 fatty acid amide derivative cocamidopropyl 5.0 (Cognis) with betaine structure (approx. betaines 45%) PLANTACARE ® 818 UP C 8 - C 16 fatty alcohol Coco Glucoside 5.0 (Cognis) glycoside (approx. 50%) LAMESOFT ® PO 65 Coco-Glucoside (and) Coco-Glucoside (and) 5.0 (Cognis) Glyceryl Oleate Glyceryl Oleate Herbasol Extract Valerian 5.0 Sodium Chloride 1.8
  • Viscosity (mPas), Brook.RVF, 23 ° C, spindle 4, 10 rpm 4100
  • Foam bath constituent Chemical name INCI name% by weight TEXAPON ® NSO sodium lauryl ether sulfate Sodium Laureth Sulfate 27.0 (approx. 28%) PLANTACARE ® 818 UP C 8 - C 16 fatty alcohol coco glucoside 9.0 glycoside (approx. 50%) DEHYTON ® PK 45 Real betaine, fatty acid cocamidopropyl 4.0 amide derivative with betaine betaine structure (approx. 45%) GLUADIN ® W 40 partial hydrolyzate from Hydrolyzed Wheat 4.0 wheat protein Herbasol extract valerian 1.0 sodium chloride sodium chloride 0.3 water ad 100
  • Cleansing milk ingredient Chemical name INCI name% by weight EMULGADE ® SE Mixture of partial glyceryl stearate (and) 6.0 (Cognis) glycerides, fatty alcohols, Ceteareth20 (and) wax esters and ethoxy-Cetearethl2 (and) lated fatty alcohols Cetearyl Alcohol (and) Cetyl Palmitate EUTANOL ® G (Cognis) 2-octyldodecanol octyldodecanol 7.0 (Guerbet alcohol) valerian oil 2.0
  • CETIOL ® 868 (Cognis) isooctyl Octyl Stearate 8.0 3.0 Glycerol 86% Carbopol ® carbomer 981/2% 10.0 (Goodrich) swelling NaOH 10% 0.8 water ad 100
  • Viscosity (mPas), Brookfield RVF, 23 ° C, spindle. 5, 10 rpm 8,000
  • Hand dishwashing detergent component Chemical name% by weight C 13/17 alkanesulfonate alkanesulfonate C 13/17 (approx. 60%) 19.5 TEXAPON ® N 70 (Cognis) lauiyl ether sulfate, Na salt (approx. 9.0 70%) DEHYTON ® K (Cognis) fatty acid amide derivative with 13.3 betaine structure approx. 30%> D, L-3,3-GLUCOPON ® 600 CS UP alkyl polyglucoside approx. 50% 14.0 (Cognis) Ethanol 5.0 Herbasol extract valerian 0.5 water ad 100 pH 5-6
  • Fabric softener ingredient Chemical name% by weight DEHYQUART ® AU 56 Esterquat (Cognis, approx. 80%) 16.7 Calcium Chloride (25%) 0.5 Herbasol extract valerian 0.65 Water ad 100
  • the coloring cream had a pH of 10.0. It caused an intense red tint of the hair.
  • Emulsifier TD9 / PEG40HCO 56 0.5 0.5 0.5

Abstract

L'invention concerne des compositions pour nettoyer des surfaces, ces compositions contenant de l'extrait de valériane destiné à apaiser la peau de l'utilisateur lors de l'utilisation desdites compositions.
EP04765860A 2003-10-15 2004-10-06 Produits contenant de la valeriane Ceased EP1675564A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10348680A DE10348680A1 (de) 2003-10-15 2003-10-15 Mittel enthaltend Baldrian
PCT/EP2004/011179 WO2005037242A1 (fr) 2003-10-15 2004-10-06 Produits contenant de la valeriane

Publications (1)

Publication Number Publication Date
EP1675564A1 true EP1675564A1 (fr) 2006-07-05

Family

ID=34428481

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04765860A Ceased EP1675564A1 (fr) 2003-10-15 2004-10-06 Produits contenant de la valeriane

Country Status (3)

Country Link
EP (1) EP1675564A1 (fr)
DE (1) DE10348680A1 (fr)
WO (1) WO2005037242A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016174011A1 (fr) 2015-04-28 2016-11-03 Cutech Srl Compositions comprenant des extraits de valériane

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006133897A2 (fr) * 2005-06-13 2006-12-21 Gerd-Rudolf Meilke Produit de traitement de surface et procede de production de ce produit
DE102005042603A1 (de) * 2005-09-07 2007-03-08 Henkel Kgaa Hautpflegendes Handgeschirrspülmittel
US8450378B2 (en) 2006-02-09 2013-05-28 Gojo Industries, Inc. Antiviral method
US9629361B2 (en) 2006-02-09 2017-04-25 Gojo Industries, Inc. Composition and method for pre-surgical skin disinfection
US8119115B2 (en) 2006-02-09 2012-02-21 Gojo Industries, Inc. Antiviral method
US8618175B2 (en) * 2010-07-19 2013-12-31 Brussels Ventures Corp. Ultrasound medical gel composition etherified hydroxyethylcellulose
DE102011089576A1 (de) * 2011-12-22 2013-06-27 Henkel Ag & Co. Kgaa Mildes Gesichtsreinigungsmittel mit Haut pflegenden Eigenschaften

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH470885A (de) * 1964-09-11 1969-04-15 Huber Xaver Verfahren zur Herstellung eines Badezusatzes
DE3583379D1 (de) * 1984-11-14 1991-08-08 Int Flavors & Fragrances Inc Verfahren, zusammensetzungen und ihre anwendungen gegen stress.
US5578312A (en) * 1993-05-05 1996-11-26 Parrinello; Vincene M. Skin care system and method for improving moisture retention in skin
FR2730634A1 (fr) * 1995-02-17 1996-08-23 Khayat Hanna Produits cosmetiques a pouvoir calmant
US6315980B1 (en) * 1998-09-25 2001-11-13 Shiseido Company, Ltd. Skin barrier function recovery and promotion composition and evaluation method thereof
EP1293554A4 (fr) * 2000-06-20 2004-12-22 Shiseido Co Ltd Parfums attenuant le stress et compositions attenuant le stress, contenant lesdits parfums
DE10062610A1 (de) * 2000-12-15 2002-06-27 Merz & Co Gmbh & Co Vesikelbildende Hautöle aus öllöslichen Komponenten und W/O-Emulgatoren nit einem HLB-Wert von 2-6 und vesikelbildenden Lipiden sowie wahlweise einem oder mehreren üblichen Zusatzstoffen, Verfahren zu deren Herstellung und ihre Verwendung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2005037242A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016174011A1 (fr) 2015-04-28 2016-11-03 Cutech Srl Compositions comprenant des extraits de valériane

Also Published As

Publication number Publication date
DE10348680A1 (de) 2005-05-12
WO2005037242A1 (fr) 2005-04-28

Similar Documents

Publication Publication Date Title
US6858216B2 (en) Cosmetic agent containing 2-furanone derivatives
EP1326577B2 (fr) Nouvelle utilisation d'acides carboxyliques a chaine courte
EP1276451B2 (fr) Utilisation de tensioactifs a base de sucre et de glycerides partiels d'acides gras
EP1326579B1 (fr) Nouvelle utilisation d'acides carboxyliques a chaine courte
DE10240757A1 (de) Synergistische Kombination von Seidenproteinen
EP1179339B1 (fr) Produit cosmétique contenant des extraits de graines de "malvaceae"
EP1729853B1 (fr) Utilisation de derives d'amidon cationiques pour conserver les couleurs
WO2002030373A2 (fr) Nouvelle utilisation d'aldehydes a chaine courte et de composes separant le formaldehyde
EP1232739A1 (fr) Combinaisons de principes actifs comprenant des hydrocarbures et des ingrédients huileux dans une composition cosmétique
EP1339379A2 (fr) Nouvelle utilisation d'hydrolysats proteiques
EP1827354A1 (fr) Shampooing modifiant la couleur des cheveux
WO2002045665A1 (fr) Nouvelle utilisation de composes polyhydroxy
DE10163860A1 (de) Verwendung von ausgewählten kurzkettigen Carbonsäuren
EP1250906A2 (fr) Compositions pour le traitement de la peau et/ou des cheveux
EP1675564A1 (fr) Produits contenant de la valeriane
EP1513484B1 (fr) Utilisation d'ectoine ou de derives d'ectoine pour le traitement des cheveux
EP1438007A1 (fr) Nouvelle utilisation de tensioactifs derives du sucre et de glycerides partiels d'acides gras dans des colorants
WO2002045664A1 (fr) Utilisation de phospholipides dans des produits de soin capillaires
EP1786382A1 (fr) Extraits utilises comme agents de structuration
DE102004024511A1 (de) Verwendung von Polysulfiden zur Farbstabilisierung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20061009

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HENKEL AG & CO. KGAA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20091019